Bellicum pharmaceuticals presents encouraging preclinical data for gocar-nk cell program at society for immunotherapy of cancer annual meeting

Imc activation enhances innate nk cell cytotoxicity against tumor cell lines in vitro

BLCM Ratings Summary

BLCM Quant Ranking